Clinical Trials Browser

INDUSTRY × Osteosarcoma × robatumumab × Clear all

NCT00617890 2018-08-23

A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)

Phase 2 Terminated

219 enrolled 13 charts

Sarcoma, Ewing, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral